Correlation Between Nkarta and Entero Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nkarta and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Entero Therapeutics,, you can compare the effects of market volatilities on Nkarta and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Entero Therapeutics,.

Diversification Opportunities for Nkarta and Entero Therapeutics,

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Nkarta and Entero is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Nkarta i.e., Nkarta and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Nkarta and Entero Therapeutics,

Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the Entero Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Nkarta Inc is 1.52 times less risky than Entero Therapeutics,. The stock trades about -0.3 of its potential returns per unit of risk. The Entero Therapeutics, is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest  58.00  in Entero Therapeutics, on August 28, 2024 and sell it today you would lose (11.00) from holding Entero Therapeutics, or give up 18.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Nkarta Inc  vs.  Entero Therapeutics,

 Performance 
       Timeline  
Nkarta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nkarta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Entero Therapeutics, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Nkarta and Entero Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nkarta and Entero Therapeutics,

The main advantage of trading using opposite Nkarta and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.
The idea behind Nkarta Inc and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm